Literature DB >> 18824730

Validation of spectral domain optical coherence tomographic Doppler shifts using an in vitro flow model.

Larry Kagemann1, Gadi Wollstein, Hiroshi Ishikawa, Kelly A Townsend, Joel S Schuman.   

Abstract

PURPOSE: To validate velocity measurements produced by spectral domain optical coherence tomography (SD-OCT) in an in vitro laminar flow model.
METHODS: A 30-mL syringe filled with skim milk was inserted into a syringe pump. Intravenous (i.v.) tubing connected the syringe within the pump to a glass capillary tube (internal diameter, 0.579 mm) shallowly embedded in agarose gel, then to a collection reservoir. SD-OCT imaging was performed with an anterior segment eye scanner and optics engine coupled with a 100-nm bandwidth broadband superluminescent diode. Scan density of 128 x 128 A-scans was spread over a 4 x 4 mm area, and each A-scan was 2 mm in length. Fifteen sequential stationary A-scans were obtained at each 128 x 128 position, and Doppler shifts were calculated from temporal changes in phase. The beam-to-flow vector Doppler angle was determined from three-dimensional scans.
RESULTS: In all reflectance and Doppler images, a clear laminar flow pattern was observed, with v(max) appearing in the center of the flow column. Phase wrapping was observed at all measured flow velocities, and fringe washout progressively shattered reflectance and phase signals beyond the Nyquist limit. The observed percentages of the velocity profile at or below Nyquist frequency was highly correlated with the predicted percentages (R(2)=0.934; P=0.007).
CONCLUSIONS: SD-OCT provides objective Doppler measurements of laminar fluid flow in an in vitro flow system in a range up to the Nyquist limit.

Entities:  

Mesh:

Year:  2008        PMID: 18824730      PMCID: PMC2916766          DOI: 10.1167/iovs.08-2305

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Real-time measurement of in vitro flow by Fourier-domain color Doppler optical coherence tomography.

Authors:  Rainer A Leitgeb; Leopold Schmetterer; Christoph K Hitzenberger; Adolf F Fercher; Fatma Berisha; Maciej Wojtkowski; Tomasz Bajraszewski
Journal:  Opt Lett       Date:  2004-01-15       Impact factor: 3.776

2.  In vivo human retinal imaging by Fourier domain optical coherence tomography.

Authors:  Maciej Wojtkowski; Rainer Leitgeb; Andrzej Kowalczyk; Tomasz Bajraszewski; Adolf F Fercher
Journal:  J Biomed Opt       Date:  2002-07       Impact factor: 3.170

3.  Spectroscopic optical coherence tomography.

Authors:  U Morgner; W Drexler; F X Kärtner; X D Li; C Pitris; E P Ippen; J G Fujimoto
Journal:  Opt Lett       Date:  2000-01-15       Impact factor: 3.776

4.  Motion artifacts in optical coherence tomography with frequency-domain ranging.

Authors:  S H Yun; G Tearney; J de Boer; B Bouma
Journal:  Opt Express       Date:  2004-06-28       Impact factor: 3.894

5.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

6.  In vivo total retinal blood flow measurement by Fourier domain Doppler optical coherence tomography.

Authors:  Yimin Wang; Bradley A Bower; Joseph A Izatt; Ou Tan; David Huang
Journal:  J Biomed Opt       Date:  2007 Jul-Aug       Impact factor: 3.170

7.  Real-time spectral domain Doppler optical coherence tomography and investigation of human retinal vessel autoregulation.

Authors:  Bradley A Bower; Mingtao Zhao; Robert J Zawadzki; Joseph A Izatt
Journal:  J Biomed Opt       Date:  2007 Jul-Aug       Impact factor: 3.170

8.  A comparison between mean blood velocities and center-line red cell velocities as measured with a mechanical image streaking velocitometer.

Authors:  D N Damon; B R Duling
Journal:  Microvasc Res       Date:  1979-05       Impact factor: 3.514

9.  On-line volume flow rate and velocity profile measurement for blood in microvessels.

Authors:  M Baker; H Wayland
Journal:  Microvasc Res       Date:  1974-01       Impact factor: 3.514

10.  Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument.

Authors:  Akitoshi Yoshida; Gilbert T Feke; Fumihiko Mori; Taiji Nagaoka; Naoki Fujio; Hironobu Ogasawara; Suguru Konno; J Wallace Mcmeel
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

  10 in total
  5 in total

1.  Identification and assessment of Schlemm's canal by spectral-domain optical coherence tomography.

Authors:  Larry Kagemann; Gadi Wollstein; Hiroshi Ishikawa; Richard A Bilonick; Peter M Brennen; Lindsey S Folio; Michelle L Gabriele; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-17       Impact factor: 4.799

Review 2.  High-resolution ocular imaging: combining advanced optics and microtechnology.

Authors:  M Francesca Cordeiro; Robert Nickells; Wolfgang Drexler; Terete Borrás; Robert Ritch
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Sep-Oct

3.  Segmental reproducibility of retinal blood flow velocity measurements using retinal function imager.

Authors:  Jay Chhablani; Dirk-Uwe Bartsch; Lingyun Cheng; Laura Gomez; Rayan A Alshareef; Sami S Rezeq; Sunir J Garg; Zvia Burgansky-Eliash; William R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-23       Impact factor: 3.117

4.  Pilot study of Doppler optical coherence tomography of retinal blood flow following laser photocoagulation in poorly controlled diabetic patients.

Authors:  Jennifer C Lee; Brandon J Wong; Ou Tan; Sowmya Srinivas; Srinivas R Sadda; David Huang; Amani A Fawzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-09       Impact factor: 4.799

5.  In vivo label-free measurement of lymph flow velocity and volumetric flow rates using Doppler optical coherence tomography.

Authors:  Cedric Blatter; Eelco F J Meijer; Ahhyun S Nam; Dennis Jones; Brett E Bouma; Timothy P Padera; Benjamin J Vakoc
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.